ClinConnect ClinConnect Logo
Search / Trial NCT05918380

Project 3: ACHIEVE- CHD

Launched by UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER · Jun 15, 2023

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Health Disparities African American Prevention Coronary Heart Disease

ClinConnect Summary

The ACHIEVE-CHD trial is part of a larger project aimed at improving heart health and reducing health inequalities among Black and African American individuals living in Detroit and Cleveland. Specifically, this trial focuses on coronary heart disease (CHD), which is a condition that can lead to serious heart problems. The study will involve Community Health Workers (CHWs) who will provide support and education to help participants manage their health better. Participants will also receive training to ensure that the CHWs deliver effective care.

To be eligible for this study, participants must be between 40 and 75 years old, self-identify as Black or African American, and live in the Cleveland Metro Area. They should have at least two risk factors for heart disease, such as being overweight or having high blood pressure. Participants will need to complete a specific heart test and be willing to work with healthcare providers. The trial is currently recruiting participants and aims to improve heart health outcomes for those who join.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. 40 to 75 years of age
  • 2. Self-identified as Black or African American
  • 3. Residence in the Cleveland Metro Area
  • 4. Must have at least two of the following risk factors identified at a UH health fair screenings, with one risk factor being with SBP, A1c, or LDL:
  • 1. BMI≥30 mg/dL
  • 2. History of smoking
  • 3. Elevated blood pressure defined as SBP\>140 or DBP\>80 mmHg
  • 4. HbA1c≥5.7%
  • 5. LDL≥130
  • 5. Able to complete a coronary artery calcium score test (CAC)
  • 6. Willing and able to consent
  • 7. Willing to have a UH provider and UH care
  • 8. Currently insured for standard of care procedures
  • Exclusion Criteria:
  • 1. Established documented cardiovascular disease (coronary artery disease, peripheral artery disease, myocardial infarction, stroke).
  • 2. Systolic blood pressure ≥ 180 mmHg or diastolic blood pressure ≥ 110 mmHg
  • 3. Lung disease requiring supplemental oxygen therapy
  • 4. Individuals receiving treatment for cancer related disease
  • 5. Pregnant or nursing mothers

About University Hospitals Cleveland Medical Center

University Hospitals Cleveland Medical Center is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with Case Western Reserve University, the center integrates cutting-edge medical education, comprehensive patient care, and pioneering clinical trials to enhance treatment options and improve patient outcomes. With a diverse range of specialized programs and a robust infrastructure for research, University Hospitals Cleveland Medical Center plays a vital role in translating scientific discoveries into effective therapies, ensuring access to the latest advancements in medicine for patients and communities.

Locations

Cleveland, Ohio, United States

Patients applied

0 patients applied

Trial Officials

Sanjay Rajagopalan, MD

Principal Investigator

University Hospitals Cleveland Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported